Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

AstraZeneca buys a $2B stake in Summit, taking equity in bet on cancer drug

A long-speculated deal between Summit Therapeutics and AstraZeneca has finally come to fruition, but for a slice of the biotech instead of the whole pie. On Monday, the companies announced that AstraZeneca will invest $2 ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

Pennsylvania surpasses 900 measles cases

Pennsylvania on Monday surpassed 900 measles cases, after adding more than 100 additional cases in the past week. The Pennsylvania Department of Health updated its measles dashboard on Monday, putting…

More from Monday 28 September →